X
Sanofi’s Kevzara gains first approval in Canada
https://pharmaphorum.com/news/sanofis-kevzara-gains-first-approval-canada/
Rheumatoid arthritis
Delinia adds to Celgene’s immunology ambitions
Celgene continues with focus on autoimmune diseases.
Amgen’s Humira biosimilar first to gain EU nod
But patents could delay launch for more than a year.
FDA grants Roche drug fast review in GCA
Regulator grants six-month review.
GSK hires AZ’s Miels to lead pharma division
New CEO poaches Luke Miels from rival
FDA delays decision on Lilly RA hopeful
Review extended by three months.
Challenge to UK Humira patent begins
Samsung to take on patent thicket surrounding Humira.
AbbVie bullish on Humira and near-term pipeline
Sales of Humira could peak above $18 billion – CEO
Roche’s Mabthera faces cut-price competition in EU
Blockbuster likely to face cheap near-copy for first time.